19 May 2013
Keywords: merck, co, strikes, 272m, development, deal, actelion
Article | 15 December 2003
US drug major Merck & Co has entered into an agreement with Swissbiotechnology firm Actelion in a bid to beef up ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 December 2003
15 December 2003
17 May 2013
© 2013 thepharmaletter.com